SP

Subash Pariyada

Active Director Director DIN 08048894
DIN 08048894 First appointment Jan 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2018
Shareholding value •••• Premium profile

About Subash Pariyada

Data last updated:

Subash Pariyada is a Director at Grasmicrobe Private Limited (since 2018). The company operates in Pharma. Grasmicrobe Private Limited reported revenue of ₹2.16 Cr (FY 2024).

DIN 08048894
Primary Designation Director
Industry Pharma
First Appointment 11 Jan 2018
Oldest Company Age 9 yrs
Largest company Grasmicrobe Private Limited · ₹2.16 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Grasmicrobe Private Limited U01100TG2016PTC113517
Director11 Jan 20182016₹2.16 Cr (FY 2024)Active

Board colleagues of Subash Pariyada

NameDINCompanyDesignation
Raghavendra Ponnala08043171Grasmicrobe Private LimitedDirector

Directorship timeline

Open interactive timeline →
Grasmicrobe Private Limited
Premium access

Shareholding and investment profile for Subash Pariyada

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subash Pariyada

Subash Pariyada currently holds 1 directorship: Grasmicrobe Private Limited (Director, since 11 Jan 2018, revenue ₹2.16 Cr (FY 2024)).

Subash Pariyada was first appointed on 11 Jan 2018 as Director at Grasmicrobe Private Limited.

The current boards of Subash Pariyada's companies include Raghavendra Ponnala (Grasmicrobe Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available